Eager Investors Snap Up Indian IPOs On Positive Health Care Outlook

Investors upbeat about the prospects for India's health care sector have given a strong welcome to IPOs by Alkem Laboratories, the country's fifth-largest drug company in terms of domestic revenues, and Dr. Lal PathLabs which has a strong nationwide presence, as the overall first-time share sale market regains its vigor to post its best performance in five years.